Neoplasms

Symptoms and General Pathology

All Conditions

Skin and Connective Tissue Diseases

Neoplasm Metastasis

Breast Neoplasms

Lymphatic Metastasis

Breast Diseases

Skin Diseases

Neoplastic Processes

Xingfei Yu, M.D.

To establish a predicting system on axillary lymph node metastasis based on peripheral blood CK19mRNA and contrast-enhanced ultrasound.

The feasibility and predictive accuracy of peripheral blood CK19mRNA and contrast-enhanced ultrasound of axillary lymph nodes metastasis in breast cancer were verified by the data of specimen bank; to establish the evaluation system of predicting the lymph node status based on CK19 and CEUS, validate the sensitivity, specificity, negative predictive value, positive predictive value and ROC curve of the system model and use Youden index, negative likelihood ratio, positive likelihood ratio to evaluate the diagnostic efficiency.

CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer

The accuracy means the conformity of predicting results and the pathological result in lymph node involvement and also the false negative rate of sentinel lymph node (SLN) and non-SLN (nSLN) using prediction model by CK19 combined with CEUS examination

Second Affiliated Hospital, School of Medicine, Zhejiang University

Zhejiang Cancer Hospital

Breast Tumor Surgery (Department 104)

Operable Breast Cancer

Age, Continuous

Sex: Female, Male

Race (NIH/OMB)

China

Region of Enrollment

Lymph node involvement

Yu Xingfei

The Accuracy of CK19 Combined With Contrast-enhanced Ultrasound (CEUS) Predicting Value on Involved Lymph Node

Overall Study

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer	NCT02992067	Lymph Node Breastcancer		18 Years - 70 Years	Zhejiang Cancer Hospital
CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer	NCT02992067	Lymph Node Breastcancer		18 Years - 70 Years	Zhejiang Cancer Hospital

Spots Global Cancer Trial Database for ck19

Every month we try and update this database with for ck19 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for ck19

Every month we try and update this database with for ck19 cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for ck19 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.